Principal Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$141M Buy
2,321,918
+119
+0% +$6.94K 0.08% 227
2025
Q4
$125M Sell
2,321,799
-37,903
-2% -$1.82M 0.06% 241
2025
Q3
$106M Sell
2,359,702
-63,551
-3% -$2.97M 0.05% 265
2025
Q2
$112M Sell
2,423,253
-52,995
-2% -$2.6M 0.06% 258
2025
Q1
$151M Buy
2,476,248
+32,394
+1% +$1.89M 0.08% 209
2024
Q4
$138M Sell
2,443,854
-14,682
-0.6% -$820K 0.08% 224
2024
Q3
$127M Buy
2,458,536
+102,790
+4% +$4.82M 0.07% 244
2024
Q2
$97.8M Sell
2,355,746
-82,140
-3% -$3.68M 0.06% 262
2024
Q1
$132M Buy
2,437,886
+13,282
+0.5% +$677K 0.08% 220
2023
Q4
$124M Sell
2,424,604
-310,855
-11% -$16.3M 0.08% 209
2023
Q3
$159M Sell
2,735,459
-110,846
-4% -$6.79M 0.11% 171
2023
Q2
$182M Sell
2,846,305
-417,523
-13% -$28M 0.12% 165
2023
Q1
$226M Sell
3,263,828
-49,068
-1% -$3.46M 0.16% 143
2022
Q4
$238M Buy
3,312,896
+249,290
+8% +$18.8M 0.18% 133
2022
Q3
$218M Buy
3,063,606
+27,016
+0.9% +$1.96M 0.17% 136
2022
Q2
$234M Buy
3,036,590
+2,540
+0.1% +$193K 0.17% 137
2022
Q1
$222M Buy
3,034,050
+93,104
+3% +$6.25M 0.14% 162
2021
Q4
$183M Sell
2,940,946
-273,099
-8% -$16M 0.11% 190
2021
Q3
$190M Sell
3,214,045
-144,718
-4% -$9.53M 0.12% 178
2021
Q2
$224M Sell
3,358,763
-89,982
-3% -$5.87M 0.15% 164
2021
Q1
$218M Sell
3,448,745
-208,595
-6% -$13M 0.15% 155
2020
Q4
$227M Sell
3,657,340
-21,316
-0.6% -$1.31M 0.17% 147
2020
Q3
$222M Sell
3,678,656
-116,926
-3% -$7.04M 0.19% 135
2020
Q2
$223M Buy
3,795,582
+129,150
+4% +$7.72M 0.2% 135
2020
Q1
$204M Sell
3,666,432
-52,041
-1% -$3.18M 0.23% 124
2019
Q4
$239M Buy
3,718,473
+855,286
+30% +$49M 0.2% 135
2019
Q3
$145M Sell
2,863,187
-62,808
-2% -$2.95M 0.13% 200
2019
Q2
$133M Buy
2,925,995
+141,996
+5% +$6.61M 0.12% 204
2019
Q1
$133M Sell
2,783,999
-7,447
-0.3% -$371K 0.12% 197
2018
Q4
$145M Sell
2,791,446
-338,500
-11% -$18.2M 0.15% 162
2018
Q3
$194M Buy
3,129,946
+7,261
+0.2% +$431K 0.17% 136
2018
Q2
$173M Buy
3,122,685
+28,551
+0.9% +$1.54M 0.16% 150
2018
Q1
$196M Buy
3,094,134
+225,999
+8% +$14.5M 0.19% 127
2017
Q4
$176M Buy
2,868,135
+263,884
+10% +$16.5M 0.16% 156
2017
Q3
$166M Sell
2,604,251
-200,990
-7% -$11.7M 0.16% 156
2017
Q2
$156M Buy
2,805,241
+366,762
+15% +$20M 0.16% 162
2017
Q1
$133M Sell
2,438,479
-106,929
-4% -$5.86M 0.16% 147
2016
Q4
$149M Sell
2,545,408
-2,556
-0.1% -$140K 0.19% 124
2016
Q3
$137M Sell
2,547,964
-125,952
-5% -$8.09M 0.18% 129
2016
Q2
$197M Buy
2,673,916
+267,419
+11% +$18.9M 0.27% 94
2016
Q1
$154M Sell
2,406,497
-3,739
-0.2% -$236K 0.22% 115
2015
Q4
$166M Buy
2,410,236
+19,935
+0.8% +$1.32M 0.25% 107
2015
Q3
$142M Buy
2,390,301
+58,182
+2% +$3.69M 0.22% 127
2015
Q2
$155M Buy
2,332,119
+134,209
+6% +$8.84M 0.23% 124
2015
Q1
$142M Buy
2,197,910
+117,607
+6% +$7.36M 0.21% 136
2014
Q4
$123M Sell
2,080,303
-351,153
-14% -$19.8M 0.19% 143
2014
Q3
$124M Buy
2,431,456
+25,295
+1% +$1.26M 0.21% 126
2014
Q2
$117M Buy
2,406,161
+414,354
+21% +$20.4M 0.2% 135
2014
Q1
$103M Buy
1,991,807
+46,706
+2% +$2.49M 0.18% 144
2013
Q4
$103M Buy
1,945,101
+7,263
+0.4% +$370K 0.19% 138
2013
Q3
$89.7M Buy
1,937,838
+36,810
+2% +$1.62M 0.19% 148
2013
Q2
$85M Buy
+1,901,028
New +$82.5M 0.19% 143

Other funds holding BMY

Principal Financial Group's BMY Position: Q1 2026 in Review

Principal Financial Group increased its Bristol-Myers Squibb (BMY) stake by 0.01% in Q1 2026, buying an estimated $6.94K and bringing the position to 2,321,918 shares worth $141M. The position accounts for 0.08% of the portfolio, ranked #227.

Principal Financial Group first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $239M in Q4 2019. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Principal Financial Group held 2,321,918 shares of Bristol-Myers Squibb worth $141M as of Q1 2026.
  • Principal Financial Group bought 119 Bristol-Myers Squibb shares in Q1 2026, an estimated $6.94K.
  • Bristol-Myers Squibb made up 0.08% of Principal Financial Group's portfolio in Q1 2026, its #227 holding.
  • Principal Financial Group first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Principal Financial Group's Bristol-Myers Squibb position peaked at $239M in Q4 2019.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Principal Financial Group's 13F filing for Q1 2026, filed 4 May 2026.